Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2005 Apr;64(4):524–527. doi: 10.1136/ard.2003.015248

How to monitor SLE in routine clinical practice

M Fernando 1, D Isenberg 1
PMCID: PMC1755465  PMID: 15769911

Full Text

The Full Text of this article is available as a PDF (86.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gladman D. D., Urowitz M. B., Goldsmith C. H., Fortin P., Ginzler E., Gordon C., Hanly J. G., Isenberg D. A., Kalunian K., Nived O. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum. 1997 May;40(5):809–813. doi: 10.1002/art.1780400506. [DOI] [PubMed] [Google Scholar]
  2. Haq Inam, Isenberg D. A. How does one assess and monitor patients with systemic lupus erythematosus in daily clinical practice? Best Pract Res Clin Rheumatol. 2002 Apr;16(2):181–194. doi: 10.1053/berh.2002.0220. [DOI] [PubMed] [Google Scholar]
  3. Hay E. M., Bacon P. A., Gordon C., Isenberg D. A., Maddison P., Snaith M. L., Symmons D. P., Viner N., Zoma A. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med. 1993 Jul;86(7):447–458. [PubMed] [Google Scholar]
  4. Lakshminarayanan S., Walsh S., Mohanraj M., Rothfield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol. 2001 Jan;28(1):102–108. [PubMed] [Google Scholar]
  5. Manzi S., Meilahn E. N., Rairie J. E., Conte C. G., Medsger T. A., Jr, Jansen-McWilliams L., D'Agostino R. B., Kuller L. H. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997 Mar 1;145(5):408–415. doi: 10.1093/oxfordjournals.aje.a009122. [DOI] [PubMed] [Google Scholar]
  6. Morrow W. J., Williams D. J., Ferec C., Casburn-Budd R., Isenberg D. A., Paice E., Snaith M. L., Youinou P., Le Goff P. The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis. 1983 Dec;42(6):668–671. doi: 10.1136/ard.42.6.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Rahman P., Gladman D. D., Urowitz M. B., Hallett D., Tam L. S. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus. 2001;10(2):93–96. doi: 10.1191/096120301670679959. [DOI] [PubMed] [Google Scholar]
  8. Stoll T., Gordon C., Seifert B., Richardson K., Malik J., Bacon P. A., Isenberg D. A. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol. 1997 Aug;24(8):1608–1614. [PubMed] [Google Scholar]
  9. Stoll T., Seifert B., Isenberg D. A. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol. 1996 Mar;35(3):248–254. doi: 10.1093/rheumatology/35.3.248. [DOI] [PubMed] [Google Scholar]
  10. Strand V., Gladman D., Isenberg D., Petri M., Smolen J., Tugwell P. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol. 1999 Feb;26(2):490–497. [PubMed] [Google Scholar]
  11. Walz LeBlanc B. A., Gladman D. D., Urowitz M. B. Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares. J Rheumatol. 1994 Dec;21(12):2239–2241. [PubMed] [Google Scholar]
  12. Wang C., Mayo N. E., Fortin P. R. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol. 2001 Mar;28(3):525–532. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES